Syntarpen

GIF decision: Withdrawal from market, Marketing prohibition

What does this decision mean?

  • Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.
  • Zakaz wprowadzania — Selected batches are subject to a marketing prohibition — the product cannot be distributed to pharmacies.

A risk of microbiological contamination has been identified in batch 2031025 of this parenteral product (powder for solution for injection), which may lead to increased risk to patient health and inadequate medicinal product quality. Potential effects: infections, sepsis, serious complications, lack of treatment efficacy.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Syntarpen
Risk Level
Critical
Manufacturer
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
Batch Number
2031025
Notice Date
16.01.2026
View official statement

Related

Other Notices